CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX), a developer of novel biotherapeutics for unmet medical needs, announced today that George Migausky, Executive Vice President and Chief Financial Officer of Dyax, will present at the BioCentury and ThomsonReuters 17th Annual Future Leaders in the Biotech Industry Conference, being held April 8th at the Millennium Broadway Hotel in New York City. Mr. Migausky will present a corporate progress report, including an update on the Company’s commercial activities for KALBITOR® (ecallantide) and clinical development programs. The Dyax presentation is scheduled for Thursday, April 8th at 1:30 PM (ET).
